Johnson & Johnson
http://www.jnj.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Johnson & Johnson
NASH Drug Development: Experts Argue The Case For Noninvasive Tests As Surrogate Endpoints For Approval
However, FDA officials appear skeptical that imaging-based and circulating biomarkers are ready for prime time when it comes to supporting accelerated approval of drugs for noncirrhotic nonalcoholic steatohepatitis.
Relmada Hopes Open-Label Efficacy, Safety Bolster Profile Of Depression Candidate
With a pair of Phase III setbacks due to high placebo response, Relmada reports positive efficacy and safety data from an open-label trial while awaiting data from two ongoing pivotal studies for REL-1017, an NMDA antagonist.
Seelos Forges Ahead With SLS-002, Says Primary Endpoint Miss Due To Underpowered Trial
The company blamed lack of funding for incomplete enrollment of the Phase II study in acute suicidal ideation and behavior in major depressive disorder, saying it would have reached statistical significance had it fully enrolled.
Top 10 Best-Selling Drugs Of Q2 2023: COVID-19 Out, HPV In
The Merck & Co vaccine for human papillomavirus Gardasil, along with Johnson & Johnson’s Darzalex for multiple myeloma, entered the ranks of the top 10 best-selling drugs globally in the second quarter. There was no product for COVID-19 in the line-up for the first time since 2020.
Company Information
- Industry
- In Vitro Diagnostics
- Medical Devices
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Abiomed, Inc.
- Acclarent Inc.
- Actelion Pharmaceuticals Ltd.
- AdvanceCOR GmbH
- ALZA Corporation
- Alios BioPharma, Inc.
- Animas Corporation
- Aragon Pharmaceuticals, Inc.
- Auris Health, Inc.
- Auris Surgical Robotics
- BeneVir Biopharm, Inc.
- BioMedical Enterprises, Inc.
- Biosense Webster, Inc.
- Calibra Medical, Inc.
- Centyrex Internal Venture
- Cilag AG
- Cerenovus
- Codman & Shurtleff, Inc
- Coherex Medical, Inc.
- Conor Medsystems, Inc.
- Cordis Webster, Inc.
- CorImmun GmbH
- Cougar Biotechnology, Inc.
- Covagen AG
- Crucell N.V.
- DePuy Mitek, Inc.
- DePuy Orthopaedics, Inc.
- DePuy Synthes, Inc.
- Ensure Medical
- Ethicon, Inc.
- FemRx Inc.
- Flexible Stenting Solutions, Inc.
- Gynecare, Inc.
- Hansen Medical, Inc.
- Innovative Surgical Solutions, LLC
- Interventional Spine, Inc.
- Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
- Janssen Diagnostics
- Janssen Pharmaceuticals
- Janssen Vaccines & Prevention B.V.
- JointPoint, Inc.
- LifeScan, Inc.
- Medical Enterprises Distribution, LLC
- Medos International SARL
- Megadyne Medical Products, Inc.
- Mentor Corporation
- Micrus Endovascular Corporation
- Molsaic Internal Venture
- Momenta Pharmaceuticals, Inc.
- NeoStrata Company, Inc.
- Neuravi Limited
- NeuWave Medical, Inc.
- Novira Therapeutics
- Omrix Biopharmaceuticals, Inc.
- Ortho Biotech Products, L.P.
- Ortho-McNeil, Inc.
- Orthotaxy
- Peninsula Pharmaceuticals, Inc.
- Pulsar Vascular Inc
- RespiVert Ltd.
- Scios, Inc.
- Selected Nerve Stimulation Internal Ventures
- Sentio, LLC
- Sequus Pharmaceuticals
- Stem Cell Internal Venture
- Synthes, Inc.
- Tibotec
- Torax Medical, Inc.
- Triage Medical, Inc.
- Verb Surgical Inc.
- Veridex
- Vigor Sub, Inc.
- Vistakon
- XO1 Limited
- TARIS Biomedical LLC
- Verb Surgical, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice